0001062993-11-002022.txt : 20110511 0001062993-11-002022.hdr.sgml : 20110511 20110511123050 ACCESSION NUMBER: 0001062993-11-002022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110509 FILED AS OF DATE: 20110511 DATE AS OF CHANGE: 20110511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gitman Paul CENTRAL INDEX KEY: 0001375378 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 11831016 MAIL ADDRESS: STREET 1: 167 EXECUTIVE DRIVE CITY: MANHASSET HILLS STATE: NY ZIP: 11040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0303 4 2011-05-09 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001375378 Gitman Paul 167 EXECUTIVE DRIVE MANHASSET HILLS NY 11040 1 0 0 0 Common Stock, $0.001 par value 2011-05-09 4 M 0 15000 0.83 A 56425 D Stock Option (Right to Buy) 0.83 2011-05-09 4 M 0 15000 0.00 D 2016-09-05 Common Stock, $0.001 par value 15000 0 D The option became exercisable in twelve equal monthly installments beginning on October 6, 2006. /s/ Paul Gitman by Carl A. Valenstein, attorney in fact 2011-05-11